Studies probe value and impact of direct-to-consumer genetic testing

Brigham Women's Hospital |
December 2016
Press Release

Despite being on the market for nearly a decade, direct-to-consumer (DTC) genetic testing continues to be controversial among experts and raises concerns among health care providers and regulatory agencies. The NIH-funded “Impact of Personal Genomics (PGen) Study” addresses these concerns by empirically measuring the perceptions and tracking the behaviors of individuals who have received DTC genetic testing from two separate companies.

Latest News From Genomes2People